Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Sandor

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1986
Central antiarrhythmic effects of imidazole in anesthetized ratsB Cuparencu, L Safta, V Sandor, et al.
Journal of Chromatography. B, Biomedical Applications|November 3, 1995
Quantitation of the diastereoisomers of L-buthionine-(R,S)-sulfoximine in human plasma: a validated assay by capillary electrophoresisV Sandor, T Flarakos, G Batist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Synchronous inflammatory breast cancer and advanced ovarian carcinoma: a case with prolonged disease-free survivalV Sandor, E Reed, G Sarosy, et al.
British Journal of Cancer|August 23, 2000
P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228V Sandor, A Senderowicz, S Mertins, et al.
Molecular Pharmacology|November 6, 1998
Using the national cancer institute anticancer drug screen to assess the effect of MRP expression on drug sensitivity profilesM Alvarez, R Robey, V Sandor, et al.
Anti-Cancer Drugs|September 23, 2000
FR901228 causes mitotic arrest but does not alter microtubule polymerizationV Sandor, A R Robbins, R Robey, et al.
Blood|October 25, 2001
Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case reportR L Piekarz, R Robey, V Sandor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
SarCNU, a nitrosourea analog on a day 1, 5, and 9 oral schedule: a phase I and pharmacokinetic study in patients with advanced solid tumorsL Panasci, S F Stinson, D Melnychuk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase II trial of chemotherapy alone for primary CNS and intraocular lymphomaV Sandor, V Stark-Vancs, D Pearson, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1986
Central antiarrhythmic effects of imidazole in anesthetized ratsB Cuparencu, L Safta, V Sandor, et al.
Journal of Chromatography. B, Biomedical Applications|November 3, 1995
Quantitation of the diastereoisomers of L-buthionine-(R,S)-sulfoximine in human plasma: a validated assay by capillary electrophoresisV Sandor, T Flarakos, G Batist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Synchronous inflammatory breast cancer and advanced ovarian carcinoma: a case with prolonged disease-free survivalV Sandor, E Reed, G Sarosy, et al.
British Journal of Cancer|August 23, 2000
P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228V Sandor, A Senderowicz, S Mertins, et al.
Molecular Pharmacology|November 6, 1998
Using the national cancer institute anticancer drug screen to assess the effect of MRP expression on drug sensitivity profilesM Alvarez, R Robey, V Sandor, et al.
Anti-Cancer Drugs|September 23, 2000
FR901228 causes mitotic arrest but does not alter microtubule polymerizationV Sandor, A R Robbins, R Robey, et al.
Blood|October 25, 2001
Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case reportR L Piekarz, R Robey, V Sandor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
SarCNU, a nitrosourea analog on a day 1, 5, and 9 oral schedule: a phase I and pharmacokinetic study in patients with advanced solid tumorsL Panasci, S F Stinson, D Melnychuk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase II trial of chemotherapy alone for primary CNS and intraocular lymphomaV Sandor, V Stark-Vancs, D Pearson, et al.
Pageof 2